Search
for
Sort by
Research 451–480 of 1000+
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Prophylaxis and Management of Skin Toxicities
- Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on hair growth phases over a shorter timeframe
- Iodoterapia e seus Efeitos Colaterais no Tratamento de Neoplasia de Tireoide
- Management of Dermatologic Toxicities
- Cutaneous complications of chemotherapeutic agents
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Spironolactone for treatment of female pattern hair loss
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Combination and rotational therapy in androgenetic alopecia
- 5α-Reduced glucocorticoids: a story of natural selection
- A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Mechanism-Based Strategies for Prevention of Taxane-Induced Hair Follicle Damage in Cancer Chemotherapy
- Photodynamic therapy as a new therapeutic approach of oral lichen planus
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Benign Cutaneous Eruptions After Transplantation
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Self-Amplifying RNA Approach for Protein Replacement Therapy
- Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- The use of complementary and alternative medicine among dermatology outpatients in Eastern Turkey
- Ultraviolet Radiation in Wound Care: Sterilization and Stimulation